Morningstar
•
Sep 22, 2025
Pfizer Inc.: Pfizer: Metsera Acquisition Puts Firm Back in Contention in Potential $200 Billion GLP-1 Market
Summary
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: The Procter & Gamble Company
Aug 31, 2026
•
PG
Weekly Stock List
Aug 31, 2026
•
TGT, CVS, DE, LNG, EL, BJ, LEA, PWR, WMB, JCI, APA, SJM, XYZ, ALC, LLY, ANF, CMI, PLTR, WMT, VGNT
Technical Assessment: Bullish in the Intermediate-Term
Aug 31, 2026
•
TWLO, MRK
Daily Spotlight: Value Versus Growth Investing
Aug 28, 2026
•
BMY
Analyst Report: Verizon Communications Inc.
Aug 25, 2026
•
VZ
